Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

961
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
961
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

773
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
773

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Frontal Release Signs and Future Decline in Research Participants With Intact Cognition.

JAMA network open·2026
Same author

Multimodal Free-Water Imaging Links Cardiometabolic Risk to Periarterial Dysfunction and Amyloid Accumulation in Early Alzheimer's.

Research square·2026
Same author

Frequency of mixed neuropathologies in individuals with down syndrome with and without Alzheimer's dementia.

Acta neuropathologica·2026
Same author

Elevated levels of circulating plasma sPDGFRβ in cognitively impaired APOE4 carriers.

GeroScience·2026
Same author

Segmentation and morphometry of intracranial internal carotid artery calcification in relation to brain atrophy.

Neuroradiology·2026
Same author

Reply to Comment on "Delayed Disease Onset Report in UK Biobank: Implications for Prodromal Studies in Parkinson's Disease".

Movement disorders : official journal of the Movement Disorder Society·2026

Related Experiment Video

Updated: May 6, 2026

Middle Cerebral Artery Occlusion Allowing Reperfusion via Common Carotid Artery Repair in Mice
06:59

Middle Cerebral Artery Occlusion Allowing Reperfusion via Common Carotid Artery Repair in Mice

Published on: January 23, 2019

18.8K

APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis.

Kristiina Rannikmäe1, Rajesh N Kalaria, Steven M Greenberg

  • 1Division of Clinical Neurosciences, Centre for Clinical Brain Sciences, University of Edinburgh, , Edinburgh, UK.

Journal of Neurology, Neurosurgery, and Psychiatry
|October 29, 2013
PubMed
Summary

The APOE-ε4 gene variant may be linked to severe cerebral amyloid angiopathy (CAA), a condition associated with brain bleeds. However, the APOE-ε2 variant

Keywords:
AmyloidApolipoproteinsCerebrovascular DiseaseMeta-AnalysisSystematic Reviews

More Related Videos

A Modified Surgical Model of Hind Limb Ischemia in ApoE-/- Mice using a Miniature Incision
05:47

A Modified Surgical Model of Hind Limb Ischemia in ApoE-/- Mice using a Miniature Incision

Published on: May 13, 2021

3.3K
Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

21.1K

Related Experiment Videos

Last Updated: May 6, 2026

Middle Cerebral Artery Occlusion Allowing Reperfusion via Common Carotid Artery Repair in Mice
06:59

Middle Cerebral Artery Occlusion Allowing Reperfusion via Common Carotid Artery Repair in Mice

Published on: January 23, 2019

18.8K
A Modified Surgical Model of Hind Limb Ischemia in ApoE-/- Mice using a Miniature Incision
05:47

A Modified Surgical Model of Hind Limb Ischemia in ApoE-/- Mice using a Miniature Incision

Published on: May 13, 2021

3.3K
Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

21.1K

Area of Science:

  • Neurology
  • Genetics
  • Pathology

Background:

  • Cerebral amyloid angiopathy (CAA) is a significant cause of lobar intracerebral haemorrhage (ICH).
  • The apolipoprotein E (APOE) gene, particularly the ε4 allele, is linked to CAA presence, while both APOE-ε4 and ε2 alleles are associated with lobar ICH.
  • Current understanding suggests APOE-ε4 promotes amyloid deposition, and APOE-ε2 promotes severe CAA with vasculopathy leading to ICH.

Purpose of the Study:

  • To evaluate the allele-specific effects of APOE genotypes on the severity of cerebral amyloid angiopathy.
  • To assess the association between APOE-ε4 and APOE-ε2 genotypes and the progression to severe CAA.

Main Methods:

  • Systematic identification of published studies with APOE genotype and postmortem brain histopathology data for CAA severity.
  • Meta-analysis of available published and unpublished data to determine the effects of ε4-containing (ε4+) and ε2-containing (ε2+) genotypes on severe CAA progression.

Main Results:

  • Meta-analyses indicated a possible association between ε4+ genotypes and severe CAA (OR 2.5, 95% CI 1.4 to 4.5).
  • No significant association was found for ε2+ genotypes with severe CAA, though the small sample size (22 participants) limited reliable conclusions.
  • Data from six studies involving 543 participants (353 with CAA) were included in the analyses.

Conclusions:

  • A potential link exists between the APOE-ε4 genotype and severe CAA.
  • The study did not find a significant association for APOE-ε2 with severe CAA, but this requires further investigation due to limited data.
  • Additional research is necessary to fully clarify the allele-specific roles of APOE in CAA and its underlying mechanisms.